lumos-pharma.com (LUMO): Dana dhuwit perusahaan

Logo korporat perusahaan Lumos Pharma Corp (LUMO)

Lumos Pharma, Inc. (LUMO) develops oral treatments for rare metabolic pathologies, leveraging patent protection within niche markets. Growth is expected following the publication of test results for its growth hormone deficiency therapy. The cash volume trend, where the indicator value reaches 0.01, confirms asset liquidity, complementing the company's ESG strategy focused on bioethics and production energy efficiency.

Lumos Pharma Corp - Volume dana dhuwit perusahaan LUMO (periode 04.07.2022 - 21.12.2024)

Ringkesan rincian data analitis Lumos Pharma Inc (LUMO)

- nilai saham lan prakiraan konsensus rega:
Analisis dhasar perusahaan:Lumos Pharma, Inc. LUMO
Produk mawa merek Lumos Pharma

The market assesses Lumos Pharma, Inc. (LUMO) as a high-risk asset with growth potential. This indicator measures immediate solvency by tracking liquidity balances available to cover short-term liabilities. Analyzing the volume of highly liquid cash allows for monitoring the R&D burn rate. For a biotech company, this is a critical marker of sustainability until the completion of LUM-201 trials. The stock is classified as a speculative instrument dependent on secondary offerings.

Pesaing langsung

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|Gunggung dana dhuwit perusahaan GPCR (Structure Therapeutics Inc.)|MDXG: Dhuwit awis perusahaan|Rezolute - Gunggung dana dhuwit perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis perusahaan|Dhuwit awis perusahaan MBX Bio|Dhuwit awis perusahaan ALT|AARD: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SGMT|Dana dhuwit perusahaan BIOA (BioAge Labs)|Volume dana dhuwit perusahaan BMEA (Biomea Fusion Corp)|Sisa dhuwit perusahaan QNCX|GUTS - Dana dhuwit perusahaan|VTVT - Volume dana dhuwit perusahaan|Agape ATP Corp. (ATPC) - Dana dhuwit perusahaan|Pluri Inc (PLUR) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Synlogic|Dana dhuwit perusahaan LPCN|Dana dhuwit perusahaan Matinas BioPharma Holdings, Inc. (MTNB)|Spruce Biosciences - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Galecto Corporation GLTO|Gunggung dana dhuwit perusahaan CTCX (Carmell)|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)